Orion Biotech Opportunities Corp. (ORIAU) Stock Analysis

What Orion Biotech Opportunities Corp. does

Orion Biotech Opportunities Corp. functions as a special purpose acquisition company (SPAC). Its core mission involves completing a business combination, which encompasses various forms such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more target companies or enterprises. This entity was established in 2021 and maintains its headquarters in New York, New York.

Key metrics

ETFs linked to ORIAU

Broad-market and Financial Services sector ETFs an investor holding Orion Biotech Opportunities Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ORIAU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Orion Biotech Opportunities Corp.?

Orion Biotech Opportunities Corp. trades under the ticker ORIAU on NASDAQ.

Which exchange is ORIAU listed on?

ORIAU is listed on NASDAQ.

What sector does Orion Biotech Opportunities Corp. operate in?

Orion Biotech Opportunities Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze ORIAU in a portfolio?

PortView shows ORIAU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.